Lexicon Pharmaceuticals | 流动负债



金融业
股票价格
USD
资产
USD 225.58M
现金及等价物
USD 21.36M
销售成本
USD 17.81M
流动资产
USD 145.08M
流动负债
USD 34.84M
债务
USD 99.27M
股息收益率
0
EBIT
USD -49.63M
EBITDA
USD -49.48M
员工
285
EPS每股收益
USD -0.17
股本和储备
USD 129.44M
销售毛利
USD -16.16M
债务利息支出
USD 2.21M
贷款资金
USD 56.11M
市值
USD 306.6M
净收入
USD -53.43M
营业费用
USD 57M
营业利润
USD -55.35M
普通股股本
USD 245K
PE价格收益
12.44
税前利润
USD -53.43M
销售收入
USD 1.65M
销售和管理费用
USD 39.19M
股票
USD 168K
贸易债权人
USD 5.9M
应收帐款人
USD 2.62M


流动负债 更改 日
Abbott USD 14.58B 1.14B 2025-09
Acadia Pharmaceuticals USD 356.58M 26.56M 2025-09
Agios Pharmaceuticals USD 74.76M 4.35M 2025-09
Akebia Therapeutics USD 133.38M 14.66M 2025-09
Alnylam Pharmaceuticals USD 1.56B 254.63M 2025-09
AstraZeneca USD 30.62B 3.44B 2025-12
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Coherus Biosciences USD 372.3M 108.67M 2025-09
Eli Lilly USD 40.14B 1.12B 2025-09
Esperion Therapeutics USD 359.03M 60.24M 2025-09
Halozyme Therapeutics USD 837.23M 702.95M 2025-09
Illumina USD 1.59B 377M 2025-12
Insmed USD 417.21M 105.53M 2025-09
Ironwood Pharmaceuticals USD 242.5M 9.98M 2025-09
J&J USD 50.87B 3.31B 2025-09
Lexicon Pharmaceuticals USD 34.84M 75.86M 2025-06
MacroGenics USD 44.47M 5.47M 2025-09
MannKind USD 109.13M 2.7M 2025-09
Merck USD 28.63B 2.59B 2025-09
Moderna USD 1.68B 109M 2025-09
Novartis USD 32B 286M 2025-09
PTC Therapeutics USD 866.24M 238.44M 2025-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
Thermo Fisher Scientific USD 15.19B 301M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
United Therapeutics USD 546.3M 19.2M 2025-09
Vanda Pharmaceuticals USD 117.87M 3.62M 2025-09


Lexicon Pharmaceuticals 流动负债 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.